Understanding how tumors affect immune responses in cancer treatment
Center for Multiparametric Imaging of Tumor Immune Microenvironments
This study is looking at how tough tumors make it for the immune system to fight cancer, with the hope of finding better ways to boost T cell therapies for patients with hard-to-treat cancers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10991432 on NIH RePORTER |
What this research studies
This research investigates the dynamics of immune microenvironments in solid tumors that are difficult to treat. By using advanced imaging techniques and data analysis, the project aims to uncover how tumors hinder the effectiveness of immune responses and therapies. The goal is to identify the physical and molecular barriers that limit T cell function in these environments, which could lead to improved strategies for engineering T cell therapies. Patients may benefit from insights that could enhance the effectiveness of immunotherapies for advanced cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with advanced solid tumors who are undergoing or considering immunotherapy.
Not a fit: Patients with early-stage cancers or those not receiving immunotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapy treatments for patients with advanced solid tumors.
How similar studies have performed: Other research has shown promising results in understanding tumor-immune interactions, making this approach both relevant and potentially impactful.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Provenzano, Paolo — University of Minnesota
- Study coordinator: Provenzano, Paolo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.